F.C.T.A. Solidarité: périodique des travailleurs du commerce, des transports et de l'alimentation
Zurich. La Fédération.

F.C. Terborgh, schrijverschap in wording: brieven van Reijnier Flaes aan Axel Huber
Terborgh, F. C ; Rosendahl Huber, A ; Huber, Axel
Maarssen. De Ploeg. c1995. 234 p.
ISBN 9065840575

[F.C. Tomlinson et al vs. Dillon, Read & Co. and Goodyear Tire and Rubber Company court proceedings]
Dillon, Clarence
[1926-1927]. 4 pamphlets.

FC Vignoble-Cully, 1900-2000: cent ans de sport et d'amitié
Trolliet, Michel ; Noverraz, Marc-Henri
[Cully. FC Vignoble-Cully. 2000]. 87 p.

F.C. Weiskopf
Arndt, Franziska
Leipzig. Bibliographisches Institut. 1965. 96 p.

F. C. Weiskopf, Schriftsteller und Kritiker: z. Entwicklung seiner literar. Anschauungen
Hiebel, Irmfried
Berlin. Weimar. 1973. 398 p.

F.C. Weiskopf und die Tschechoslowakei
Václavek, Ludvík
Praha. Státní pedagogické nakl. 1965. 103 p.

Fū Dō
Tonami, Mamoru ; Miyazaki, Ichisada
Tōkyō. Jinbutsu Ōraisha. Shōwa 41[1966]. 286 p.,[l] leaf of plates.

FDA: apple juice is safe to drink
[Rockville, Md.]. U.S. Food and Drug Administration. [2011]. 1 online resource (2 p.).

FDA: the nation's premier consumer protection and health agency
Rockville, MD. U.S. Dept. of Health and Human Services, U.S. Food and Drug Administration. [2003?]. 1 folded sheet (6 p.).

The FDA
Lucas, Scott
Millbrae, Calif. Celestial Arts. c1978. vi, 184 p.
ISBN 0890872155

FDA administrative enforcement manual
Parker, Florence R
Boca Raton, FL. Taylor & Francis. c2005. xx, 456 p.
ISBN 084933067X

FDA almanac
Rockville, MD. Office of Public Affairs, Food and Drug Administration, Public Health Service, Dept. of Health & Human Services. v.

The FDA and the Chilean grape scare
Tornel, Valeria
1990 May. 68 leaves.

The FDA and the future of American biomedical and food industries: hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, tiotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995
Washington. U.S. G.P.O. 1995. iv, 202 p.
ISBN 0160472784

FDA and the veterinarian
Rockville, MD (7500 Standish Place, Rockville 20855). U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Veterinary Medicine. [1994]. 42 p.

The FDA and worldwide quality system requirements guidebook for medical devices
Daniel, Amiram ; Kimmelman, Ed ; Trautman, Kimberly A
Milwaukee, Wis. ASQ Quality Press. 2008. xxx, 304 p.
ISBN 9780873897402

The FDA and worldwide quality system requirements guidebook for medical devices
Trautman, Kimberly A
Milwaukee, Wis. ASQC Quality Press. c1997. vi, 210 p.
ISBN 0873893778

FDA annual report
[Rockville, Md.]. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration. 2 v.

FDA approvalof generic drugs: new sources of approval payoff and reputation risk
Liu, Tina
2011. 64 leaves.

FDA at Irvine: Zimmer Gunsul Frasca Partnership
Palmer, Sarah ; Sul, Nancy ; Barreneche, Raul A
New York. Edizione Press. c2005. 106 p.
ISBN 1931536309

Fód a'bháis, agus gearr-sgéalta eile
Máire
Baile Átha Cliath. Oifig an tSoláthair. 1955. 192 p.

FDA biotechnology inspection guide: reference materials and training aids
[Rockville, Md.?]. U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration. [1991]. 48 p.

FDA can further improve its adverse drug reaction reporting system: report to the Secretary of Health and Human Services
Washington. The Office. [1982]. iv, 28 p.

FDA cautions against using unapproved IUD's
[Silver Spring, Md.].

FDA chemistry project
Washington. v.

FDA clinical experience abstracts
[Washington]. Food and Drug Administration. v.

FDA consumer
[Rockville, Md. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration. 1972-. v.

FDA consumer nutrition knowledge survey: a nationwide study of food shopper's knowledge, beliefs, attitudes and reported behavior regarding food and nutrition, [factors related to nutrition labeling]
[Washington]. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Bureau of Foods, Office of Nutrition and Consumer Sciences, Division of Consumer Studies. [1976-]. v.

FDA consumer protection activities--FDA reorganization: Hearings, Ninety-first Congress, first and second session
Washington. U.S. Govt. Print. Off. 1970. vi, 484 p.

FDA Counterfeit Drug Task Force interim report: safe & secure
Rockville, Md. U.S. Dept. of Health and Human Services, Food and Drug Administration. [2003]. 1 online resource (ii, 40 p.).

FDA criminal enforcement: how to prevent and defend against liability
Kowal, Steven M
Washington, D.C. Washington Legal Foundation. c1992. vi, 67 p.

FDA directory
Washington, D.C. Food and Drug Law Institute. v.

FDA drug approval: review time has decreased in recent years : report to congressional requesters
Washington, D.C. The Office. 1995]. 44 p.

FDA drug approval, a lengthy process that delays the availability of important new drugs: report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
Washington, D.C. U.S. General Accounting Office. 1981. vi, 83 p.

FDA drug bulletin
Rockville, Md. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration. [1971-1990]. v.

FDA drug experience monthly bulletin
Washington D.C. Food and Drug Administration, U.S. Dept. of Health, Education and Welfare. v.

FDA enforcement report
Rockville, Md. The Office. v.

FDA enforcement story
Rockville, Md. Division of Compliance Policy. v.

FDA export reform
Washington, D.C. The Office. 1995]. 10, [2] p.

FDA Export Reform and Enhancement Act of 1995: hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995
Washington. U.S. G.P.O. 1995. iii, 59 p.
ISBN 0160475945

The FDA follies
Burkholz, Herbert
New York, NY. BasicBooks. c1994. xii, 228 p.
ISBN 046502369X

The FDA food additive review process: backlog and failure to observe statutory deadline : fourth report
Washington. U.S. G.P.O. 1995. v, 14 p.

FDA import automation: serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives
Washington, D.C. The Office. 1995]. 22 p.

FDA, inside & out
Parisian, S
Front Royal, VA. Fast Horse Press. c2001. xix, 647 p.
ISBN 0970710917

FDA integrity issues: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on Visx Inc. document disclosure, July 31, 1996
Washington. U.S. G.P.O. 1996. iii, 83 p.
ISBN 0160534666

FDA introduction to total drug quality
[Rockville, Md. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration. 1973]. 101 p.

FDA law weekly
Atlanta, Ga. NewsRx. v.

F. Dall'Ongaro e il suo epistolario scelto ricordi e spogli
De Gubernatis, Angelo ; Dall'Ongaro, Francesco
Firenze. Tip. editrice dell'associazione. 1875. 400 p.

FDA medical bulletin
Rockville, MD. Dept. of Health & Human Services, Public Health Service, Food and Drug Administration. [1991]-1999. 9 v.

FDA medical device approval: is there a better way? : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, June 2, 2011
Washington. U.S. G.P.O. 2011. 1 online resource (iii, 87 p.).

FDA Medical Library serials holdings list
Bullock, Sylvia A ; Cheng, Wendy W
Rockville, Md. U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research. 1995. 126 p.

FDA medical product approvals: hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
Washington. U.S. G.P.O. 1997. iii, 55 p.
ISBN 0160541662

FDA, Merck, and Vioxx, putting patient safety first?: hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004
Buffalo, N.Y. William S. Hein. 2012. iv, 971 p.

FDA Modernization Act: implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
Washington. U.S. G.P.O. 2000. iv, 189 p.
ISBN 0160600871

FDA narcotic treatment programs directory
Rockville, Md. U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration. [1991]. ii, 176 p.

FDAnews device daily bulletin
Falls Church, Va. Washington Business Information.

FDAnews Drug Daily Bulletin
District of Columbia. Federal Information & News Dispatch, Inc.

FDAnews Marketing and Sales Bulletin
United States,District of Columbia. Federal Information & News Dispatch, Inc.

FDAnews Nutraceutical Weekly Bulletin
Falls Church, VA. Washington Business Information.

F. Daniel Frost and the rise of the modern American law firm
Massaro, Toni Marie
Tuscon. University of Arizona Press. c2011. xvi, 224 p., [16] p. of plates.
ISBN 9781888965117

FDA oversight: blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997
Washington. U.S. G.P.O. 1998. iii, 427 p.
ISBN 0160561035

FDA oversight--food inspection: Hearings, Ninety-second Congress, first session
Washington. U.S. Govt. Print. Off. 1972. vi, 474 p.

FDA papers
Washington, D.C. U.S. Food and Drug Administration. 1967-1972. 6 v.

FDA policy on home drug testing kits: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997
Washington. U.S. G.P.O. 1997. iii, 81 p.
ISBN 0160542960

FDA program drug inspection program: a system at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, November 1, 2007
Washington. U.S. G.P.O. 2008. iii, 421 p.
ISBN 9780160825613

FDA reform legislation: hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996
Washington. U.S. G.P.O. 1996. iv, 458 p.
ISBN 0160535255

FDA regulated products & pregnant women: executive summary
[Washington, D.C.?]. U.S. Food and Drug Administration, Office of Women's Health. [1994?]. 52 p.

FDA regulation of blood safety: notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997
Washington. U.S. G.P.O. 1997. iii, 300 p.
ISBN 0160559847

FDA regulation of medical devices
Thompson, Bradley Merrill
Buffalo Grove, IL. Interpharm Press. c1995. xviii, 497 p.
ISBN 0935184791

FDA regulation of medical devices, including the status of breast implants: joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995
Washington, DC. U.S. G.P.O. [1996]. vi, 206 p.
ISBN 0160522226

FDA regulatory affairs: a guide for prescription drugs, medical devices, and biologics
Pisano, Douglas J ; Mantus, David
New York. Informa Healthcare USA. c2008. viii, 448 p.
ISBN 9781420073546

FDA report on enforcement and compliance
Washington, D.C. The Administration. 1963-. v.

FDA report on the oral contraceptives
[Washington. For sale by the Supt. of Docs., U.S. Govt. Print. Off.]. 1966. iii, 104 p.

FDA reports of suspected adverse reactions to drugs and therapeutic devices
Washington, D.C. Food and Drug Administration, U.S. Dept. of Health, Education, and Welfare. v.

FDA resources
Washington, D.C. The Office. 1996]. 46, [2] p.

FDA's approval of the Today contraceptive sponge: hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, July 13, 1983
Washington. U.S. G.P.O. 1984. iv, 520 p.

FDA's Center for Devices and Radiological Health: a profile
[Washington, D.C.?]. The Center. [1995]. 12 p., 11, [1] leaves.

FDA's creative application of the law: not merely a collection of words : a consideration of FDA's implementation of its statutory authority to adapt to the practical demands on regulation presented by innovation, increased scientific understanding, limited resources, and change in public health policy
Degnan, Fred H
Washington, D.C. FDLI. c2000. v, 182 p.
ISBN 1885259646

FDA's diversity databank
Rockville, MD (5600 Fishers Lane, Rockville 20857). Dept. of Health and Human Services, Food and Drug Administration. [1998?]. 1 folded sheet (6 p.).

FDA's drug approval process: up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Washington. U.S. G.P.O. 2005. iii, 93 p.
ISBN 0160726891

FDA's foreign drug inspection program: weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008
Washington. U.S. G.P.O. 2008. iii, 262 p.
ISBN 9780160845277

Födas på nytt: dikter
Thiel, Tage
Lidingö. NY Nords förlag. [1942]. 99 p.

FDA's regulation of food imports: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, June 16, 1993
Washington. U.S. G.P.O. 1993. ii, 172 p.
ISBN 0160414547

FDA's regulation of gentian violet appears reasonable: report
Washington, D.C. U.S. General Accounting Office. [1980]. iv, 78 p.

FDA's role in protecting the public health: examining FDA's review of safety and efficacy concerns in anti-depressant use by children : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 23, 2004
Washington. U.S. G.P.O. 2005. iii, 633 p.
ISBN 0160743273

FDA's role in the evaluation of Avandia's safety: hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007
Washington. U.S. G.P.O. 2008. iii, 138 p.
ISBN 9780160825880

FDA veterinarian
[Rockville, MD. U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Veterinary Medicine. 1986-. v.

F. David, coup d'œil sur sa vie et son œuvre
Azevedo, Alexis
Paris. Au Ménestrel, Heugel et cie. 1863. 1 p. l., 99, [1] p. 1 port., facsims. (3 L).

FDA Week
United States. Inside Washington Publishers.